Capecitabine and Oxaliplatin in Treating Patients With Advanced or Metastatic Colorectal Cancer
Status:
Completed
Trial end date:
2004-04-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Combining more than one drug may kill more tumor cells.
PURPOSE: Phase I/II trial to study the effectiveness of combining capecitabine and
oxaliplatin in treating patients who have advanced or metastatic colorectal cancer that
cannot be surgically removed.